Hudson Edge Investment Partners Inc. Purchases 52,043 Shares of AdaptHealth Corp. $AHCO

Hudson Edge Investment Partners Inc. increased its position in shares of AdaptHealth Corp. (NASDAQ:AHCO) by 84.4% during the first quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 113,679 shares of the company’s stock after buying an additional 52,043 shares during the quarter. Hudson Edge Investment Partners Inc.’s holdings in AdaptHealth were worth $1,353,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also added to or reduced their stakes in the company. Vanguard Group Inc. increased its holdings in shares of AdaptHealth by 4.4% during the fourth quarter. Vanguard Group Inc. now owns 11,768,599 shares of the company’s stock valued at $117,215,000 after acquiring an additional 491,106 shares in the last quarter. Deerfield Management Company L.P. lifted its holdings in shares of AdaptHealth by 15.9% in the 3rd quarter. Deerfield Management Company L.P. now owns 11,477,730 shares of the company’s stock worth $102,726,000 after purchasing an additional 1,572,835 shares in the last quarter. Reinhart Partners LLC. grew its position in AdaptHealth by 10.6% in the 4th quarter. Reinhart Partners LLC. now owns 8,100,785 shares of the company’s stock valued at $80,684,000 after purchasing an additional 773,727 shares during the period. Dimensional Fund Advisors LP increased its stake in AdaptHealth by 7.0% during the 4th quarter. Dimensional Fund Advisors LP now owns 6,402,699 shares of the company’s stock valued at $63,773,000 after purchasing an additional 420,629 shares in the last quarter. Finally, Geode Capital Management LLC increased its stake in AdaptHealth by 0.8% during the 4th quarter. Geode Capital Management LLC now owns 2,627,306 shares of the company’s stock valued at $26,173,000 after purchasing an additional 19,998 shares in the last quarter. Institutional investors own 82.67% of the company’s stock.

Analysts Set New Price Targets

Several research analysts have weighed in on AHCO shares. Truist Financial upped their price objective on shares of AdaptHealth from $13.00 to $14.00 and gave the stock a “buy” rating in a report on Monday, April 13th. Royal Bank Of Canada lifted their price objective on shares of AdaptHealth from $13.00 to $15.00 and gave the company an “outperform” rating in a report on Monday, May 11th. Robert W. Baird set a $18.00 target price on shares of AdaptHealth in a research report on Wednesday, May 6th. Jefferies Financial Group restated a “hold” rating and issued a $11.00 target price on shares of AdaptHealth in a report on Monday, April 20th. Finally, UBS Group dropped their price target on shares of AdaptHealth from $15.00 to $14.00 and set a “buy” rating on the stock in a research report on Wednesday, May 6th. Five research analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $14.29.

Insiders Place Their Bets

In other AdaptHealth news, insider Russell E. Schuster III sold 11,275 shares of AdaptHealth stock in a transaction that occurred on Monday, June 1st. The shares were sold at an average price of $10.06, for a total transaction of $113,426.50. Following the transaction, the insider owned 136,538 shares of the company’s stock, valued at $1,373,572.28. This trade represents a 7.63% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Company insiders own 1.95% of the company’s stock.

AdaptHealth Price Performance

AHCO opened at $10.76 on Friday. AdaptHealth Corp. has a 1 year low of $8.51 and a 1 year high of $13.43. The company has a debt-to-equity ratio of 1.21, a current ratio of 0.92 and a quick ratio of 0.71. The company has a market capitalization of $1.46 billion, a price-to-earnings ratio of -17.35, a P/E/G ratio of 0.55 and a beta of 1.45. The firm’s fifty day moving average price is $10.66 and its two-hundred day moving average price is $10.61.

AdaptHealth Company Profile

AdaptHealth, Inc operates as a leading provider of home medical equipment (HME) and related services in the United States. The company focuses on delivering respiratory care, mobility solutions and bathroom safety products to patients with chronic and acute medical needs. Through its comprehensive service offerings, AdaptHealth aims to enhance quality of life and clinical outcomes for patients who require long-term support outside of a hospital setting.

The company’s respiratory portfolio includes products such as continuous positive airway pressure (CPAP) devices, oxygen concentrators, ventilators, and associated supplies for patients with sleep apnea, COPD and other pulmonary conditions.